Blockchain Registration Transaction Record

Nutriband CEO Discusses AVERSA™ Tech to Combat Opioid Crisis on Podcast

Nutriband CEO Gareth Sheridan discusses AVERSA™ abuse-deterrent technology on Jack Neel Podcast, targeting opioid crisis with transdermal fentanyl patches to reduce misuse and accidental exposure.

This news matters because the opioid crisis remains a severe public health emergency, with fentanyl and similar drugs contributing to thousands of overdoses and deaths annually. Nutriband's AVERSA™ technology represents a proactive approach to mitigating abuse and accidental exposure, which could enhance patient safety and reduce societal harm. By developing abuse-deterrent transdermal patches, the company addresses a critical gap in pain management, potentially influencing regulatory standards and healthcare practices. For investors and stakeholders, this innovation signals growth opportunities in the pharmaceutical sector, while for the general public, it offers hope for safer medication options that balance therapeutic access with risk reduction.